Propofol vs Sevoflurane: Clinical Comparison
Both propofol and sevoflurane are clinically equivalent for maintenance of general anesthesia with equal patient outcomes, but your choice should prioritize patient-specific factors: use propofol for smoother emergence with less postoperative agitation and nausea in outpatient settings, and sevoflurane for faster extubation times and mask induction in pediatric or difficult airway cases 1, 2.
Key Clinical Differences
Induction Characteristics
Propofol provides faster IV induction (2.2 minutes vs 3.1 minutes for sevoflurane mask induction), but sevoflurane offers the unique advantage of smooth mask induction without respiratory irritability 3. For adults requiring rapid sequence induction, propofol is superior. For pediatric patients or those with difficult IV access, sevoflurane's nonpungent odor makes it ideal for mask induction 2.
Induction side effects differ significantly:
- Sevoflurane mask induction: higher rates of airway excitement, cough (6%), breathholding (6%), agitation (6%), laryngospasm (5%) 3
- Propofol IV induction: less airway irritation, but greater hypotension (MAP drops to ~71-73 mmHg vs 80 mmHg with sevoflurane) 4
Recovery Profile
Sevoflurane consistently produces faster emergence and extubation times 2, 5:
- Emergence: 8-11 minutes (sevoflurane) vs 10-13 minutes (propofol)
- Extubation: 8-9 minutes (sevoflurane) vs 10 minutes (propofol)
- Response to commands: 9-13 minutes (sevoflurane) vs 11-14 minutes (propofol)
This faster recovery with sevoflurane is statistically significant but the clinical difference is modest (2-3 minutes) 6.
Postoperative Complications
Propofol has a superior side effect profile for outpatient surgery 7:
- Postoperative nausea/vomiting: Significantly less with propofol (meta-analysis shows sevoflurane increases PONV risk)
- Postoperative agitation: Significantly less with propofol (P = 0.04) 6
- Patient satisfaction: Higher with propofol due to less PONV 7
However, sevoflurane shows less intraoperative patient movement during procedures requiring immobility 5.
Hemodynamic Stability
Sevoflurane provides more stable hemodynamics:
- Less hypotension during induction and maintenance 5, 4
- Requires significantly less phenylephrine support 5
- Dose-dependent cardiac depression but no tachycardia at <2 MAC 2
Propofol causes more pronounced hypotension, particularly in patients on ARBs or with cardiovascular compromise 8.
Dosing and Maintenance
Propofol
- Induction: 1-2.5 mg/kg IV (reduce to 1-1.5 mg/kg in elderly/compromised patients)
- Maintenance: 6-12 mg/kg/hr infusion or target-controlled infusion (TCI) targeting 2-4 µg/mL effect-site concentration
- Monitor depth with BIS/processed EEG to minimize consumption 1
Sevoflurane
- Induction: 5-8% inhaled concentration with gradual uptitration
- Maintenance: 1-3% (age-dependent; ~2% in adults at 1 MAC)
- Use low fresh gas flows (≤2 L/min) to reduce environmental impact 1
- Monitor end-tidal concentration with depth of anesthesia monitoring 1
Special Populations
Elderly Patients
No significant difference in cognitive outcomes (POCD, delirium) between agents 6. Choose based on other factors:
- Sevoflurane: faster extubation
- Propofol: less postoperative agitation
Pediatric Patients
Sevoflurane is preferred for mask induction due to nonpungent odor and lack of respiratory irritability 2. Faster emergence times (12 vs 19 minutes compared to halothane), though slightly higher postoperative agitation (14% vs 10%).
Cancer Surgery
Propofol may be preferable for colon cancer surgery, showing less impact on coagulation function (smaller increases in D-dimer and fibrinogen) and better preservation of immune function (IgM, IgG, NK cells) compared to sevoflurane 9.
Neurosurgery
Sevoflurane shows advantages in interventional neuroradiology with faster recovery, less patient movement, and more stable hemodynamics when depth is controlled with BIS monitoring 5.
Environmental Considerations
The 2024 French Society of Anesthesia guidelines emphasize that clinical benefit must take priority over environmental concerns 1:
- Sevoflurane has greenhouse gas emissions but lower carbon footprint than desflurane/isoflurane
- Propofol has ecotoxicity concerns (found in wastewater, drinking water, fish) and plastic waste from TIVA equipment
- Recommendation: "With equal clinical benefit for the patient, anesthesia professionals utilize either maintained general anesthesia by inhaled vapors, or total intravenous general anesthesia by propofol" 1
Mitigation strategies if using sevoflurane:
- Use low fresh gas flows (<2 L/min)
- Monitor depth of anesthesia to reduce vapor consumption
- Consider vapor-capture technology where available
Clinical Decision Algorithm
Choose Propofol when:
- Outpatient/ambulatory surgery (less PONV, higher satisfaction)
- Patient history of severe PONV
- Need for smooth, calm emergence
- Cancer surgery requiring immune preservation
- Contraindication to volatile agents (malignant hyperthermia susceptibility)
Choose Sevoflurane when:
- Pediatric patients requiring mask induction
- Difficult IV access
- Need for fastest possible extubation
- Procedures requiring absolute immobility
- Hemodynamically unstable patients
- Cardiovascular surgery or patients on ARBs
Either agent is appropriate when:
- Routine inpatient surgery in healthy adults
- Elderly patients (no difference in cognitive outcomes)
- Neurosurgery (with depth monitoring)
Critical Pitfalls to Avoid
- Don't use sevoflurane without low fresh gas flows - wastes agent and increases environmental impact 1
- Don't assume faster emergence with sevoflurane translates to faster discharge - overall recovery room times are similar 2
- Don't neglect depth monitoring - both agents benefit from BIS/processed EEG to optimize dosing and reduce consumption 1
- Don't switch agents based solely on environmental concerns - patient safety and clinical appropriateness must come first 1
- Monitor fluoride levels with prolonged sevoflurane (>2 MAC-hours) in patients with renal impairment 2